Literature DB >> 26375644

[The list of drugs in the Popular Pharmacy Program and the Brazilian National Pharmaceutical Care Policy].

Sueli Miyuki Yamauti1, Silvio Barberato-Filho2, Luciane Cruz Lopes2.   

Abstract

This study aimed to analyze the list of drugs in the Popular Pharmacy Program in Brazil (PFPB) in relation to the country's pharmaceutical care policy. The list of drugs in the PFPB was compared to the Brazilian and international reference lists of essential medicines, the components of pharmaceutical care in Brazilian Unified National Health System (SUS), and drug production by the country's government pharmaceutical laboratories. The PFPB list includes 119 drugs, of which 19.3% and 47.1% were not selected on the Brazilian and international reference lists, respectively; 16.8% are not used in primary care, and 40.3% are not produced by the country's government laboratories. A revision of the PFPB list based on the essential medicines concept (World Health Organization), alignment of pharmaceutical care policies, and production by government laboratories are essential to improve quality of health care, management, training of prescribers, and information for the population.

Mesh:

Substances:

Year:  2015        PMID: 26375644     DOI: 10.1590/0102-311X00054814

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  1 in total

1.  Cultural Sensitivity and Global Pharmacy Engagement in Latin America: Argentina, Brazil, Ecuador, Guatemala, and Mexico.

Authors:  Sally L Haack; Inbal Mazar; Erin M Carter; Joyce Addo-Atuah; Melody Ryan; Laura Leticia Salazar Preciado; Luis Renee González Lucano; Aliz Lorena Barrera Ralda
Journal:  Am J Pharm Educ       Date:  2019-05       Impact factor: 2.047

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.